December 2023
Volume 23, Issue 15
Open Access
Optica Fall Vision Meeting Abstract  |   December 2023
Contributed Session I: The perceptual experience of optogenetic vision
Author Affiliations
  • Ezgi Irmak Yücel
    Department of Psychology, University of Washington
  • Vaishnavi Mohan
    Department of Psychology, University of Washington, Seattle
  • Geoffrey M. Boynton
  • Ariel Rokem
    Department of Psychology, Center for Human Neuroscience, University of Washington, Seattle
  • Ione Fine
    Department of Psychology, Center for Human Neuroscience, University of Washington, Seattle
Journal of Vision December 2023, Vol.23, 71. doi:https://doi.org/10.1167/jov.23.15.71
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ezgi Irmak Yücel, Vaishnavi Mohan, Geoffrey M. Boynton, Ariel Rokem, Ione Fine; Contributed Session I: The perceptual experience of optogenetic vision. Journal of Vision 2023;23(15):71. https://doi.org/10.1167/jov.23.15.71.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Optogenetic therapy for retinal degenerative diseases aims to elicit light response in remaining retinal cells (bipolar and/or ganglion cells). Animal models suggest that these proteins have lower sensitivity, and slower kinetics compared to neurotypical vision. Here we describe a framework for simulating ‘virtual patients’ to quantify the predicted perceptual experience of optogenetic vision. We simulated the neural responses of rd1 mouse retina expressing 4xBGAG12,460:SNAP-mGluR2 (Holt et al., 2022) and used this simulation to generate virtual patients: sighted participants viewing the visual stimulus filtered through our simulations. We measured the visual performance of these virtual patients (n=6) using temporal contrast sensitivity functions. Virtual patients had a 10x fold loss of sensitivity, which was exacerbated at higher temporal frequencies, corresponding to a loss of Snellen acuity from ~20/40 at low temporal frequencies to ~20/100-20/200 at high temporal frequencies. We predict that the ability to process fast-moving objects may be impaired in optogenetic vision, and patients with uncontrollable nystagmus may be poor candidates for optogenetic treatments with sluggish kinetics. Our virtual patient framework can easily be extended to simulate any optogenetic protein, and thereby provides a way to quantify and compare the expected perceptual performance of different opto-proteins based on in vitro retinal data.

Footnotes
 Funding: Funding: NEI
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×